Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells
Creators
- 1. Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, 83334 Bratislava (Slovakia)
- 2. Institute for Heart Research, Slovak Academy of Sciences, Bratislava (Slovakia)
Description
Mouse leukemic cell sub-line L 1210/VCR exerts expressive multidrug resistance (MDR) that is mediated by P-glycoprotein. Cells originally adapted to vincristine are also extremely resistant to doxorubicin. Resistance to both vincristine and doxorubicin is connected with depression of drug uptake. While resistance of L 121 O cells to vincristine could be reversed by verapamil as chemo-sensitizer, resistance of cells to doxorubicin was insensitive to verapamil. Action of verapamil (well-known inhibitor of PGP activity) on multidrug resistance was often used as evidence that MDR is mediated by PGP. From this point it may be possible that the resistance of L1210/VCR cells to vincristine is mediated by PGP and the resistance to doxorubicin is mediated by other PGP-independent system. Another and more probable explanation of different effect of verapamil on resistance of L1210/VCR cells to vincristine and doxorubicin may be deduced from the following fact: Using UV spectroscopy we found that doxorubicin dissolved in water buffered medium interacts effectively with verapamil. This interaction may be responsible for the decrease of concentration of both drugs in free effective form and consequently for higher survival of cells. In contrast to doxorubicin vincristine does not give any interaction with verapamil that is measurable by UV spectroscopy and resistance of L1210/VCR cells to vincristine may be fully reversed by verapamil. (authors)
Additional details
Publishing Information
- Journal Title
- Neoplasma
- Journal Volume
- 45
- Journal Issue
- 3
- Journal Page Range
- p. 248-253
- ISSN
- 0028-2685
INIS
- Country of Publication
- Slovakia
- Country of Input or Organization
- Slovakia
- INIS RN
- 32046133
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Numerical Data
- Descriptors DEI
- ELECTRON SPECTRA; EXPERIMENTAL DATA; GLYCOPROTEINS; LABELLED COMPOUNDS; LABELLING; LEUKEMIA; NUCLEAR MEDICINE; ONCOVIN; RADIOIMMUNOASSAY; RADIONUCLIDE KINETICS; TRACER TECHNIQUES; TRITIUM
- Descriptors DEC
- ALKALOIDS; ANTIMITOTIC DRUGS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BIOASSAY; CARBOHYDRATES; DATA; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; HYDROGEN ISOTOPES; IMMUNE SYSTEM DISEASES; IMMUNOASSAY; INFORMATION; ISOTOPE APPLICATIONS; ISOTOPES; KINETICS; LIGHT NUCLEI; MEDICINE; NEOPLASMS; NUCLEI; NUMERICAL DATA; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; PROTEINS; RADIOASSAY; RADIOIMMUNODETECTION; RADIOISOTOPES; SACCHARIDES; SPECTRA; TRACER TECHNIQUES; YEARS LIVING RADIOISOTOPES
Optional Information
- Contract/Grant/Project number
- Grant SGA-VEGA-2/4127/97)
- Notes
- 4 figs., 18 refs.; Electronic version accessible via Internet: URL://www.savba.sk/logos/journals/ap/ap.html